What is Sigenics?
Sigenics has established itself over two decades as a provider of custom integrated circuit design, testing, and delivery services. The company focuses on sensor, analog, and mixed-signal applications, catering to demanding sectors such as medical, aerospace, and industrial. Their comprehensive turnkey ASIC services are designed for high reliability and innovation, including specialized expertise in reverse engineering for obsolete components to meet precise form, fit, and function requirements. Sigenics' collaborative approach ensures tailored solutions that address unique market demands, positioning them as a key partner for complex electronic system development.
How much funding has Sigenics raised?
Sigenics has raised a total of $1.4M across 3 funding rounds:
Grant
$1M
Debt
$150K
Debt
$225K
Grant (2017): $1M with participation from National Institutes of Health (NIH)
Debt (2020): $150K led by PPP
Debt (2021): $225K supported by PPP
Key Investors in Sigenics
National Institutes of Health (NIH)
The National Institutes of Health (NIH) is a primary agency of the U.S. Department of Health and Human Services, dedicated to biomedical and health-related research. Their involvement suggests a focus on Sigenics' contributions to medical technology and sensor applications.
What's next for Sigenics?
With a history of securing significant enterprise-level funding and a recent major strategic investment, Sigenics is poised for continued expansion and technological leadership. The company's focus on high-reliability applications within critical industries suggests that future capital deployment will likely target enhanced R&D capabilities, expanded manufacturing capacity, and strategic market penetration. The ongoing demand for custom ICs in sectors like medical devices and aerospace indicates a robust growth outlook, with Sigenics well-positioned to capitalize on these opportunities through further innovation and strategic partnerships.
See full Sigenics company page
